Axsome’s Wait Pays Off With Broad Auvelity Label For Major Depression

Major depressive disorder
Axsome thinks differentiated label will help Auvelity compete in genericized market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip